期刊文献+

肺癌靶向治疗新进展及展望 被引量:12

Recent advances and prospect in targeted therapy for lung cancer
下载PDF
导出
摘要 近年来,靶向药物治疗已全面改变了肺癌的诊疗模式,并显著地改善了肺癌患者的生存期和生活质量。药物的更新迭代、靶向治疗模式的优化、耐药机制的探索、新靶点新药物的研发,不断地丰富肺癌靶向治疗的内容。针对驱动基因阳性肺癌的靶向治疗最新进展和未来方向进行综述。 During the past years,targeted agents have dramatically changed the diagnosis and treatment paradigm of lung cancer,which also have significantly improved the survival and quality of life for patients with lung cancer.With the innovations of targeted agents,the optimization of modes of targeted treatment,the exploration of mechanisms of drug resistance and the research and development of novel targets and drugs,the context of targeted therapy in lung cancer is largely enriched.In this paper,we discussed the recent advances and future direction of targeted therapy for driver mutation positive lung cancer.
作者 洪少东 张力 HONG Shaodong;ZHANG Li(Department of Medical Oncology,Sun Yat-sen University Cancer Center,Guangzhou 510060,Guangdong Province,China)
出处 《中国癌症杂志》 CAS CSCD 北大核心 2020年第10期733-743,共11页 China Oncology
关键词 肺癌 驱动基因 靶向治疗 耐药 Lung cancer Driver gene Targeted therapy Drug resistance
  • 相关文献

参考文献1

二级参考文献1

共引文献6

同被引文献167

引证文献12

二级引证文献57

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部